v3.25.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Net sales $ 879 $ 953
Cost of products sold 413 447
Gross profit 466 506
Selling, general, and administrative expenses 358 415
Research and development expenses 36 42
Intangible asset impairments 0 6
Restructuring and other costs 9 1
Operating income 63 42
Other income and expenses:    
Interest expense, net 19 18
Other (income) expense, net 0 (7)
Income before income taxes 44 31
Provision for income taxes 25 14
Net income 19 17
Less: Net loss attributable to noncontrolling interests (1) (1)
Net income attributable to Dentsply Sirona $ 20 $ 18
Earnings per common share attributable to Dentsply Sirona:    
Basic (in dollars per share) $ 0.10 $ 0.09
Diluted (in dollars per share) $ 0.10 $ 0.09
Weighted average common shares outstanding:    
Basic (in shares) 199.1 207.4
Diluted (in shares) 199.8 208.5